Global Blood Therapeutics (GBT) Tops Q2 EPS by 7c

Global Blood Therapeutics (NASDAQ: GBT) reported Q2 EPS of ($1.12), $0.07 better than the analyst estimate of ($1.19). Revenue for the quarter came in at $47.6 million versus the consensus estimate of $43.84 million.

For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c